Cinzia Cocola

Cinzia Cocola

Auto-generated profile, based on publicly available information

Cinzia Cocola

Institute of Biomedical Technologies, National Research Council, Milan, Italy

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2009 in Reproduction in Domestic Animals
Verified
Journal Article
Closed access
PDF file
CCC Cocola
C Cocola
PAP Anastasi
P Anastasi
ASAstigiano Simonetta
Astigiano Simonetta
EPEleonora Piscitelli
Eleonora Piscitelli
PPParide Pelucchi
Paride Pelucchi
IZI Zucchi
I Zucchi

28 November 2016 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
CCCinzia Cocola
Cinzia Cocola
SMStefano Molgora
Stefano Molgora
EPEleonora Piscitelli
Eleonora Piscitelli
MVMaria Cristina Veronesi
Maria Cristina Veronesi
MGMarianna Greco
Marianna Greco
Antonio GiordanoAntonio Giordano
Antonio Giordano

4 November 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
IZIleana Zucchi
Ileana Zucchi
ASAstigiano Simonetta
Astigiano Simonetta
GBG. Bertalot
G. Bertalot
SSS. Sanzone
S. Sanzone
CCC. Cocola
C. Cocola
RDR. Dulbecco
R. Dulbecco
Tumors derived from rat LA7 cancer stem cells (CSCs) contain a hierarchy of cells with different capacities to generate self-renewing spheres and tubules serially ex vivo and to evoke tumors in vivo . We isolated two morphologically distinct cell types with distinct tumorigenic potential from LA7-evoked tumors: cells with polygonal morphology that are characterized by expression of p21/ WAF1 and p63 and display hallmarks of CSCs and elongated epithelial cells, which generate tumors with far less heterogeneity than LA7 CSCs. Serial transplantation of elongated epithelial cells results in progressive loss of tumorigenic potential; tumor heterogeneity; CD44, E-cadherin, and epithelial cytokeratin expression and increased α-smooth muscle actin I and vimentin expression. In contrast, serial transplantation of LA7 CSCs can be performed indefinitely and results in tumors that maintain their heterogeneity, consistent with self-renewal and multilineage differentiation potential. Collectively, our data show that polygonal cells are CSCs, whereas epithelial elongated cells are lineage-committed progenitors with tumorigenic potential, and suggest that tumor progenitors, although lacking indefinite self-renewal potential, nevertheless may make a substantial contribution to tumor development. Because LA7 cells can switch between conditions that favor maintenance of pure CSCs vs. differentiation into other tumor cell types, this cell system provides the opportunity to study factors that influence CSC self-renewal and differentiation. One factor, p63 , was identified as a key gene regulating the transition between CSCs and early progenitor cells.

29 October 2014
Verified
Book Chapter
Closed access
PDF file
EPEleonora Piscitelli
Eleonora Piscitelli
CCCinzia Cocola
Cinzia Cocola
FTFrank Rüdiger Thaden
Frank Rüdiger Thaden
PPParide Pelucchi
Paride Pelucchi
BGBrian Gray
Brian Gray
IZIleana Zucchi
Ileana Zucchi

14 May 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
SKSampath Kumar Katakam
Sampath Kumar Katakam
PPParide Pelucchi
Paride Pelucchi
CCCinzia Cocola
Cinzia Cocola
RRRolland Reinbold
Rolland Reinbold
IVIsrael Vlodavsky
Israel Vlodavsky
Martin GötteMartin Götte
Martin Götte
The heparan sulfate proteoglycan Syndecan-1 binds cytokines, morphogens and extracellular matrix components, regulating cancer stem cell properties and invasiveness. Syndecan-1 is modulated by the heparan sulfate-degrading enzyme heparanase, but the underlying regulatory mechanisms are only poorly understood. In colon cancer pathogenesis, complex changes occur in the expression pattern of Syndecan-1 and heparanase during progression from well-differentiated to undifferentiated tumors. Loss of Syndecan-1 and increased expression of heparanase are associated with a change in phenotypic plasticity and an increase in invasiveness, metastasis and dedifferentiation. Here we investigated the regulatory and functional interplay of Syndecan-1 and heparanase employing siRNA-mediated silencing and plasmid-based overexpression approaches in the human colon cancer cell line Caco2. Heparanase expression and activity were upregulated in Syndecan-1 depleted cells. This increase was linked to an upregulation of the transcription factor Egr1, which regulates heparanase at the promoter level. Inhibitor experiments demonstrated an impact of focal adhesion kinase, Wnt and ROCK-dependent signaling on this process. siRNA-depletion of Syndecan-1, and upregulation of heparanase increased the colon cancer stem cell phenotype based on sphere formation assays and phenotypic marker analysis (Side-population, NANOG, KLF4, NOTCH, Wnt, and TCF4 expression). Syndecan-1 depletion increased invasiveness of Caco2 cells in vitro in a heparanase-dependent manner. Finally, upregulated expression of heparanase resulted in increased resistance to radiotherapy, whereas high expression of enzymatically inactive heparanase promoted chemoresistance to paclitaxel and cisplatin. Our findings provide a new avenue to target a stemness-associated signaling axis as a therapeutic strategy to reduce metastatic spread and cancer recurrence.

1 September 2008 in Cytotechnology
Verified
Journal Article
Open access
PDF file
CCCinzia Cocola
Cinzia Cocola
SSSveva Sanzone
Sveva Sanzone
ASAstigiano Simonetta
Astigiano Simonetta
PPParide Pelucchi
Paride Pelucchi
EPEleonora Piscitelli
Eleonora Piscitelli
IZIleana Zucchi
Ileana Zucchi
The cancer stem cell hypothesis posits that tumors are derived from a single cancer-initiating cell with stem cell properties. The task of identifying and characterizing cancer-initiating cells with stem cell properties at the single cell level has proven technically difficult because of the scarcity of the cancer stem cells in the tissue of origin and the lack of specific markers for cancer stem cells. Here we show that a single LA7 cell, derived from rat mammary adenocarcinoma has: the ability to serially re-generate mammospheres in long-term non-adherent cultures, the differentiation potential to generate all the cell lineages of the mammary gland and branched duct-like structures that recapitulate morphologically and functionally the ductal–alveolar-like architecture of the mammary tree. The properties of self-renewal, extensive capacity for proliferation, multi-lineage differentiation and the tubular-like structure formation potential suggest that LA7 cells is a cancer stem model system to study the dynamics of tumor formation at the single cell level.